MedImmune, Inc.'s Update To Investors At Goldman, Sachs & Co. Healthcare Conference Highlights Progress Of Key Programs And Initiatives

GAITHERSBURG, Md., June 14 /PRNewswire-FirstCall/ -- Today at the Goldman Sachs Twenty-Seventh Annual Global Healthcare Conference, MedImmune's (Nasdaq: MEDI - News) chief executive officer and president, David M. Mott, will discuss recent progress at the company, including the following: